{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:06:55Z","timestamp":1792735615513,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Membranous nephropathy (MN) is a major pattern of nephrotic syndrome (NS) in adults. Some MN have secondary causes and some may be accompanied with other glomerular diseases. MN patients coexisting with amyloidosis are very rare, and mostly was polytypic MN. Herein, we describe the first report which identifying monotype PLA2R-MN (\u03ba light chain) concurrent with leukocyte chemotactic factor 2 amyloidosis (ALECT2). This rare case highlights the importance of renal pathology for diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We describe a case of a 60-year-old male patient with persistent proteinuria and low serum albumin for nine months. No monoclonal component was revealed by serum and urine immunofixation electrophoresis but serum PLA2R antibody was positive. The patient was empirically treated with Leflunomide and Losartan, but edema was not improved. The diagnosis of renal pathology is PLA2R-related monotypic (IgG-\u03ba positive) MN concurrent with ALECT2. Methylprednisolone, cyclosporine A and anticoagulant (rivaroxaban) were prescribed resulting in a complete remission of NS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>MN patients concurrent with ALECT2 presented massive proteinuria or NS. When nephrotic range proteinuria is present in ALECT2, it is important to consider that it may be due to a concomitant underlying nephropathy especially MN and treated according to MN will get good therapeutic effect.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-023-03331-x","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T14:02:59Z","timestamp":1695736979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["First case report of PLA2R-related monotypic (IgG-\u03ba positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinjie","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"3331_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000348638","volume":"181","author":"X Pan","year":"2013","unstructured":"Pan X, Xu J, Ren H, et al. Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China. Contrib Nephrol. 2013;181:22\u201330. https:\/\/doi.org\/10.1159\/000348638.","journal-title":"Contrib Nephrol"},{"issue":"3","key":"3331_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1053\/j.ajkd.2020.10.009","volume":"77","author":"L Alsharhan","year":"2021","unstructured":"Alsharhan L, Beck LH Jr. Membranous Nephropathy: Core Curriculum 2021. Am J Kidney Dis. 2021;77(3):440\u201353. https:\/\/doi.org\/10.1053\/j.ajkd.2020.10.009.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"3331_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/BF00465597","volume":"378","author":"A Bohle","year":"1978","unstructured":"Bohle A, Fischbach H, G\u00e4rtner HV, et al. Simultaneous occurrence of perimembranous glomerulonephritis and glomerular amyloidosis. Virchows Arch A Pathol Anat Histol. 1978;378(4):315\u201320. https:\/\/doi.org\/10.1007\/BF00465597.","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"7","key":"3331_CR4","first-page":"19","volume":"53","author":"VA Varshavski\u012d","year":"1991","unstructured":"Varshavski\u012d VA, Luarinavichius AA, Severgina ES. Membranous nephropathy associated with kidney amyloidosis (Russian). Arkh Patol. 1991;53(7):19\u201323.","journal-title":"Arkh Patol"},{"issue":"6","key":"3331_CR5","first-page":"577","volume":"21","author":"H Chen","year":"2012","unstructured":"Chen H, Zeng CH, Liu ZH. Membranous nephropathy with systemic amyloidosis. J Nephrol Dialy Transplant. 2012;21(6):577\u201381.","journal-title":"J Nephrol Dialy Transplant"},{"issue":"2","key":"3331_CR6","first-page":"145","volume":"35","author":"YM Gao","year":"2019","unstructured":"Gao YM, Liu GP, Zhao XL. Idiopathic membranous nephropathy with renal amyloidosis: a case report. Chin J Nephrol. 2019;35(2):145\u20136.","journal-title":"Chin J Nephrol"},{"issue":"5","key":"3331_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pathol.2021.08.008","volume":"54","author":"A Morel","year":"2022","unstructured":"Morel A, Buob D, Goujon JM, et al. Thrombospondin type-1 domain-containing 7A-related membranous nephropathy associated with glomerular AL amyloidosis. Pathology. 2022;54(5):654\u20137. https:\/\/doi.org\/10.1016\/j.pathol.2021.08.008.","journal-title":"Pathology"},{"issue":"6","key":"3331_CR8","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/ki.2014.389","volume":"87","author":"G Gregorini","year":"2015","unstructured":"Gregorini G, Izzi C, Ravani P, et al. Tubulointerstitial nephritis is a dominant feature of hereditary apolipoprotein A-I amyloidosis. Kidney Int. 2015;87(6):1223\u20139. https:\/\/doi.org\/10.1038\/ki.2014.389.","journal-title":"Kidney Int"},{"key":"3331_CR9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/ki.2013.558","volume":"86","author":"SM Said","year":"2014","unstructured":"Said SM, Sethi S, Valeri AM, et al. Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosis. Kidney Int. 2014;86:370\u20137. https:\/\/doi.org\/10.1038\/ki.2013.558.","journal-title":"Kidney Int"},{"key":"3331_CR10","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/ki.2014.11","volume":"86","author":"CP Larsen","year":"2014","unstructured":"Larsen CP, Kossmann RJ, Beggs ML, et al. Clinical, morphologic, and genetic features of renal leukocyte chemotactic factor 2 amyloidosis. Kidney Int. 2014;86:378\u201382. https:\/\/doi.org\/10.1038\/ki.2014.11.","journal-title":"Kidney Int"},{"issue":"2","key":"3331_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/13506129.2020.1722097","volume":"27","author":"DY Li","year":"2020","unstructured":"Li DY, Liu D, Wang SX, et al. Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients. Amyloid. 2020;27(2):134\u201341. https:\/\/doi.org\/10.1080\/13506129.2020.1722097.","journal-title":"Amyloid"},{"issue":"5","key":"3331_CR12","doi-asserted-by":"publisher","first-page":"532","DOI":"10.3760\/cma.j.cn112151-20200825-00662","volume":"50","author":"J Li","year":"2021","unstructured":"Li J, Wang WF, Liu JH, et al. Leukocyte chemotactic factor 2-associated renal amyloidosis coexisting with PLA2R-mediated idiopathic membranous nephropathy report of a case. Chin J Pathol. 2021;50(5):532\u20134. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20200825-00662.","journal-title":"Chin J Pathol"},{"issue":"6","key":"3331_CR13","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.ekir.2017.07.008","volume":"2","author":"A Best Rocha","year":"2017","unstructured":"Best Rocha A, Larsen CP. Membranous glomerulopathy with light chain-restricted deposits: a clinicopathological analysis of 28 cases. Kidney Int Rep. 2017;2(6):1141\u20138. https:\/\/doi.org\/10.1016\/j.ekir.2017.07.008.","journal-title":"Kidney Int Rep"},{"issue":"12","key":"3331_CR14","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1681\/ASN.2012060577","volume":"23","author":"H Debiec","year":"2012","unstructured":"Debiec H, Hanoy M, Francois A, et al. Recurrent membranous nephropathy in an allograft caused by IgG3\u03ba targeting the PLA2 receptor. J Am Soc Nephrol. 2012;23(12):1949\u201354. https:\/\/doi.org\/10.1681\/ASN.2012060577.","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"3331_CR15","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/nep.13268","volume":"23","author":"R Ramachandran","year":"2018","unstructured":"Ramachandran R, Inamdar N, Bharati J, et al. Membranous nephropathy with light chain restricted deposits. Nephrology (Carlton). 2018;23(8):791\u20136. https:\/\/doi.org\/10.1111\/nep.13268.","journal-title":"Nephrology (Carlton)"},{"issue":"2","key":"3331_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40620-014-0042-7","volume":"27","author":"SL Hu","year":"2014","unstructured":"Hu SL, Wang D, Gou WJ, et al. Diagnostic value of phospholipase A2 receptor in idiopathic membranous nephropathy: a systematic review and meta-analysis. J Nephrol. 2014;27(2):111\u20136. https:\/\/doi.org\/10.1007\/s40620-014-0042-7.","journal-title":"J Nephrol"},{"issue":"4","key":"3331_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021;100(4):1\u2013276. https:\/\/doi.org\/10.1016\/j.kint.2021.05.021.","journal-title":"Kidney Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-023-03331-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-023-03331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T14:20:32Z","timestamp":1700490032000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-023-03331-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3331"],"URL":"https:\/\/doi.org\/10.1186\/s12882-023-03331-x","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"17 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study adheres to the tenets of the 1964 Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of this report and the accompanying images was obtained from the patient and a copy thereof is available for review by the editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}